In vitro synergistic effect of AXL, FAK and ErbB receptors inhibitors for head and neck cancer

Abstract The prognosis for patients with head and neck cancer (HNC) is usually poor, highlighting the need for new therapeutic strategies. To this end, this study aims to evaluate the antitumor efficacy of a combined treatment with low doses of different molecular targeted drugs, i.e. Y15, a FAK inh...

Descripció completa

Dades bibliogràfiques

Autors principals:	Valeria Lucarini, Valentina Angiolini, Daniela Nardozi, Monica Benvenuto, Chiara Focaccetti, Patrizia Mancini, Elena Splendiani, Tanja Milena Autilio, Claudio Cortese, Riccardo Bei, Gianluca Nicolai, Camilla Palumbo, Elisabetta Ferretti, Loredana Cifaldi, Roberto Bei, Laura Masuelli
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-07-01
Col·lecció:	Biology Direct
Accés en línia:	https://doi.org/10.1186/s13062-025-00668-1
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!